- Home
- RLAY vs DMLP Comparison
RLAY vs DMLP Comparison
Compare RLAY & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- DMLP
- Stock Information
- Founded
- RLAY 2015
- DMLP 2003
- Country
- RLAY United States
- DMLP United States
- Employees
- RLAY N/A
- DMLP N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- DMLP Oil & Gas Production
- Sector
- RLAY Health Care
- DMLP Energy
- Exchange
- RLAY Nasdaq
- DMLP Nasdaq
- Market Cap
- RLAY 1.1B
- DMLP 1.3B
- IPO Year
- RLAY 2020
- DMLP N/A
- Fundamental
- Price
- RLAY $5.11
- DMLP $33.09
- Analyst Decision
- RLAY Strong Buy
- DMLP
- Analyst Count
- RLAY 9
- DMLP 0
- Target Price
- RLAY $20.88
- DMLP N/A
- AVG Volume (30 Days)
- RLAY 1.3M
- DMLP 87.7K
- Earning Date
- RLAY 11-06-2024
- DMLP 10-31-2024
- Dividend Yield
- RLAY N/A
- DMLP 12.04%
- EPS Growth
- RLAY N/A
- DMLP 4.55
- EPS
- RLAY N/A
- DMLP 2.78
- Revenue
- RLAY $10,006,000.00
- DMLP $166,454,000.00
- Revenue This Year
- RLAY N/A
- DMLP N/A
- Revenue Next Year
- RLAY N/A
- DMLP N/A
- P/E Ratio
- RLAY N/A
- DMLP $11.88
- Revenue Growth
- RLAY N/A
- DMLP 14.26
- 52 Week Low
- RLAY $5.03
- DMLP $27.90
- 52 Week High
- RLAY $12.14
- DMLP $35.74
- Technical
- Relative Strength Index (RSI)
- RLAY 28.59
- DMLP 58.02
- Support Level
- RLAY $5.96
- DMLP $32.25
- Resistance Level
- RLAY $6.39
- DMLP $33.72
- Average True Range (ATR)
- RLAY 0.36
- DMLP 0.90
- MACD
- RLAY -0.04
- DMLP 0.01
- Stochastic Oscillator
- RLAY 5.10
- DMLP 70.85
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.